{"id":"W4390663037","doi":"10.1007/s40120-023-00570-w","title":"The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy","year":2024,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"F. Hoffmann-La Roche; Bristol-Myers Squibb","keywords":"Myostatin; Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Internal medicine; Clinical endpoint; Placebo; Endocrinology; Clinical trial; Skeletal muscle; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009600422,0.0004638664,0.0005238751,0.0004819223,0.0002694342,0.0006855286,0.0004640799,0.000822946,0.002615312],"category_scores_gemma":[0.0005127219,0.0001347854,0.0005761796,0.0002770273,0.0004241884,0.0004065245,0.0002819588,0.00144076,0.00117374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006080432,"about_ca_system_score_gemma":0.0006359144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007554963,"about_ca_topic_score_gemma":0.002457302,"domain_scores_codex":[0.9996722,0.000108701,0.00002436627,0.00005238933,0.0001042903,0.00003818496],"domain_scores_gemma":[0.9997384,0.00003859211,0.00004758206,0.00001568629,0.00006511391,0.00009468942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009601996,0.004405203,0.003205868,0.002511781,0.0004088347,0.001266565,0.0003168194,0.0015939,0.3034931,0.002170946,0.02478578,0.6462392],"study_design_scores_gemma":[0.02645737,0.1222355,0.03471166,0.001195914,0.0008359062,0.01119438,0.0002597959,0.004560841,0.2224071,0.00177955,0.57422,0.0001419789],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7084118,0.212286,0.01845762,0.007879709,0.001685383,0.002687146,0.004458358,0.001048564,0.0430855],"genre_scores_gemma":[0.9100389,0.05475047,0.0105555,0.004307343,0.0005516793,0.0008635739,0.004984678,0.00007691769,0.01387096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002615312,"threshold_uncertainty_score":0.008749068,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02643587828799274,"score_gpt":0.326808358016509,"score_spread":0.3003724797285162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}